Mei-Li Lu (Meili Lu)

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 6

Top Topics

Signaling Pathway

Top Venues

Neural plasticity

Oxidative medicine and cellular longevity

Journal of cellular and molecular medicine

Mediators of inflammation

This page only lists publications with an associated author ORCID identifier.

Publications

Yan Meng, Shengxue Yu, Fang Zhao, Meili Lu, Yue Wang, Siqi Fan, Yuhong Su, Mei-Li Lu, Hong-Xin Wang
Astragaloside IV Alleviates Brain Injury Induced by Hypoxia via the Calpain-1 Signaling Pathway. Neural plasticity 2022 (2022)
Yan Meng, Shengxue Yu, Fang Zhao, Meili Lu, Yue Wang, Siqi Fan, Yuhong Su, Mei-Li Lu, Hong-Xin Wang
Astragaloside IV Alleviates Brain Injury Induced by Hypoxia via the Calpain-1 Signaling Pathway. Neural plasticity 2022 (2022)
Yan Meng, Shengxue Yu, Fang Zhao, Meili Lu, Yue Wang, Siqi Fan, Yuhong Su, Mei-Li Lu, Hong-Xin Wang
Astragaloside IV Alleviates Brain Injury Induced by Hypoxia via the Calpain-1 Signaling Pathway. Neural plasticity 2022 (2022)
Yang Sun, Mei-Li Lu, Tairan Sun, Hong-Xin Wang
Astragaloside IV attenuates inflammatory response mediated by NLRP-3/calpain-1 is involved in the development of pulmonary hypertension. Journal of cellular and molecular medicine 25 (1) (2020)
Bin Leng, Cong Li, Yang Sun, Kun Zhao, Ling Zhang, Mei-Li Lu, Hong-Xin Wang
Protective Effect of Astragaloside IV on High Glucose-Induced Endothelial Dysfunction via Inhibition of P2X7R Dependent P38 MAPK Signaling Pathway. Oxidative medicine and cellular longevity 2020 (2020)
Bin Leng, Yingjie Zhang, Xinran Liu, Zhen Zhang, Yang Liu, Hong-Xin Wang, Mei-Li Lu
Astragaloside IV Suppresses High Glucose-Induced NLRP3 Inflammasome Activation by Inhibiting TLR4/NF-κB and CaSR. Mediators of inflammation 2019 (2019)